|
US8481043B2
(en)
*
|
2001-06-22 |
2013-07-09 |
Cpex Pharmaceuticals, Inc. |
Nasal immunization
|
|
US20100266638A1
(en)
|
2004-02-26 |
2010-10-21 |
Allergan, Inc. |
Headache treatment method
|
|
US20050191321A1
(en)
|
2004-02-26 |
2005-09-01 |
Allergan, Inc. |
Methods for treating headache
|
|
US9078892B2
(en)
*
|
2004-02-26 |
2015-07-14 |
Allergan, Inc. |
Methods for treating pain and for treating a medication overuse disorder
|
|
EP1928484B1
(en)
|
2005-08-26 |
2010-02-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treatment of headaches by administration of oxytocin
|
|
AU2006304392B2
(en)
|
2005-10-18 |
2014-05-01 |
National Jewish Health |
Conditionally immortalized long-term stem cells and methods of making and using such cells
|
|
KR20080068062A
(ko)
|
2005-11-14 |
2008-07-22 |
리나트 뉴로사이언스 코퍼레이션 |
칼시토닌 유전자-관련 펩티드에 대해 지시되는 길항제 항체및 그의 사용 방법
|
|
US20080261893A1
(en)
*
|
2006-02-24 |
2008-10-23 |
Denise Barbut |
Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
|
|
WO2007120485A2
(en)
*
|
2006-03-30 |
2007-10-25 |
Cinergen, Llc |
Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor
|
|
GB2438834A
(en)
|
2006-06-08 |
2007-12-12 |
Optinose As |
Intranasal protein administration
|
|
US7645767B2
(en)
*
|
2006-08-31 |
2010-01-12 |
Trinity Laboratories, Inc. |
Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
|
|
CA2680704A1
(en)
*
|
2007-03-12 |
2008-09-18 |
Sarentis Therapeutics, Inc. |
Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
|
|
JP2010521170A
(ja)
*
|
2007-03-13 |
2010-06-24 |
ナショナル ジューイッシュ ヘルス |
抗体の生成方法
|
|
US9707274B2
(en)
|
2007-06-08 |
2017-07-18 |
Healthpartners Research & Education |
Methods for preventing and treating post-traumatic stress disorder (PTSD)
|
|
US9808509B2
(en)
|
2007-06-08 |
2017-11-07 |
Healthpartners Research Foundation |
Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
|
|
US20100221200A1
(en)
*
|
2007-07-17 |
2010-09-02 |
The Ohio State University Research Foundation |
Compositions and methods for skin care
|
|
AU2008306192A1
(en)
*
|
2007-09-11 |
2009-04-09 |
Mondobiotech Laboratories Ag |
Use of leptin (22-56 ) as a therapeutic agent
|
|
WO2009033489A2
(en)
*
|
2007-09-11 |
2009-03-19 |
Glostrup Hospital |
Selective pacl inhibitors for use in the treatment of migraine and headaches
|
|
KR20100057050A
(ko)
*
|
2007-09-11 |
2010-05-28 |
몬도바이오테크 래보래토리즈 아게 |
치료제로서의 데슬로렐린 및 마스토파란의 용도
|
|
WO2009033781A2
(en)
*
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
|
WO2009040006A1
(en)
*
|
2007-09-11 |
2009-04-02 |
Mondobiotech Laboratories Ag |
Spantide for therapeutic uses
|
|
ES2689322T3
(es)
|
2008-03-04 |
2018-11-13 |
Teva Pharmaceuticals International Gmbh |
Métodos para tratar el dolor crónico
|
|
WO2009145956A2
(en)
*
|
2008-03-06 |
2009-12-03 |
The Trustees Of Columbia University In The City Of New York |
Uses of calpain inhibitors to inhibit inflammation
|
|
US20090246273A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Al-Ghananeem Abeer M |
Ketorolac Sublingual Spray for the Treatment of Pain
|
|
KR101803099B1
(ko)
|
2008-05-16 |
2017-11-30 |
타이가 바이오테크놀로지스, 인코포레이티드 |
항체 및 그 제조 방법
|
|
FR2932483A1
(fr)
*
|
2008-06-13 |
2009-12-18 |
Cytomics Systems |
Composes utiles pour le traitement des cancers.
|
|
ES2525411T3
(es)
*
|
2008-07-21 |
2014-12-22 |
Taiga Biotechnologies, Inc. |
Células anucleadas diferenciadas y método para preparar las mismas
|
|
ES2681478T3
(es)
|
2008-08-28 |
2018-09-13 |
Taiga Biotechnologies, Inc. |
Moduladores de MYC, métodos de uso de los mismos y métodos para identificar agentes que modulan MYC
|
|
US20110178541A1
(en)
*
|
2008-09-12 |
2011-07-21 |
Slender Medical, Ltd. |
Virtual ultrasonic scissors
|
|
US20110318345A1
(en)
*
|
2008-09-15 |
2011-12-29 |
Optinose As |
Nasal delivery
|
|
JP5706825B2
(ja)
|
2008-10-17 |
2015-04-22 |
シグネーチャー セラピューティクス, インク.Signature Therapeutics, Inc. |
フェノール性オピオイドの放出が減弱された医薬組成物
|
|
WO2010090628A2
(en)
*
|
2008-12-08 |
2010-08-12 |
Biousian Biotechnology, Inc |
Delta-opioid receptor selective analgesics
|
|
CN104523661A
(zh)
|
2009-02-06 |
2015-04-22 |
南加利福尼亚大学 |
含有单萜的治疗组合物
|
|
RU2011150521A
(ru)
*
|
2009-05-13 |
2013-06-20 |
ПРОТЕИН ДЕЛИВЕРИ СОЛЮШНЗ, ЭлЭлСи |
Фармацевтическая система для трансмембранной доставки
|
|
JP5669145B2
(ja)
*
|
2009-07-02 |
2015-02-12 |
国立大学法人山口大学 |
表面麻酔剤
|
|
KR20180052610A
(ko)
|
2009-07-27 |
2018-05-18 |
노시셉터 엘엘씨 |
통증 치료 방법
|
|
FR2948809B1
(fr)
*
|
2009-07-31 |
2012-08-17 |
St Microelectronics Rousset |
Amplificateur de lecture faible puissance auto-minute
|
|
RU2535074C2
(ru)
|
2009-08-28 |
2014-12-10 |
Лэйбрис Байолоджикс, Инк. |
Способы лечения висцеральной боли путем введения антител-антагонистов, направленных против пептида, связанного с геном кальцитонина
|
|
BR112012005124B1
(pt)
|
2009-09-08 |
2021-11-09 |
Signature Therapeutics, Inc. |
Pro-fármaco de opioide modificado por cetona, seu método de preparação, sua composição farmacêutica, sua unidade de dose, métodos e usos
|
|
JP6200648B2
(ja)
*
|
2009-12-18 |
2017-09-20 |
アケリオス セラピューティクス，インコーポレーテッド |
三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための組成物
|
|
US8622993B2
(en)
*
|
2009-12-18 |
2014-01-07 |
Healthpartners Research Foundation |
Device and method for delivering therapeutic substances to the maxillary sinus of a patient
|
|
US20110184322A1
(en)
*
|
2010-01-22 |
2011-07-28 |
Slender Medical Ltd. |
Method and device for treatment of keloids and hypertrophic scars using focused ultrasound
|
|
US8507734B2
(en)
|
2010-03-03 |
2013-08-13 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising monoterpenes
|
|
WO2011133178A1
(en)
|
2010-04-21 |
2011-10-27 |
Pharmacofore, Inc |
Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
|
|
US20110262355A1
(en)
|
2010-04-21 |
2011-10-27 |
Jenkins Thomas E |
Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
|
|
ES2710617T3
(es)
|
2010-04-21 |
2019-04-26 |
Signature Therapeutics Inc |
Composiciones que comprenden profármacos de anfetamina escindibles enzimáticamente e inhibidores de los mismos
|
|
US20130089504A1
(en)
*
|
2010-04-21 |
2013-04-11 |
Signature Therapeutics, Inc. |
Compositions Comprising Enzyme-Cleavable Hydromorphone Prodrug
|
|
US8617150B2
(en)
|
2010-05-14 |
2013-12-31 |
Liat Tsoref |
Reflectance-facilitated ultrasound treatment
|
|
US8956346B2
(en)
|
2010-05-14 |
2015-02-17 |
Rainbow Medical, Ltd. |
Reflectance-facilitated ultrasound treatment and monitoring
|
|
US9242122B2
(en)
|
2010-05-14 |
2016-01-26 |
Liat Tsoref |
Reflectance-facilitated ultrasound treatment and monitoring
|
|
US9101569B2
(en)
|
2010-05-18 |
2015-08-11 |
Universite De Geneve |
Methods for the treatment of insulin resistance
|
|
CA2801620A1
(en)
*
|
2010-07-06 |
2012-01-12 |
Gruenenthal Gmbh |
Novel gastro-retentive dosage forms comprising a gaba analog and an opioid
|
|
US9499461B2
(en)
|
2010-08-27 |
2016-11-22 |
Neonc Technologies, Inc. |
Pharmaceutical compositions comprising POH derivatives
|
|
WO2012083178A1
(en)
|
2010-12-17 |
2012-06-21 |
Neo Oncology Inc. |
Methods and devices for using isoperillyl alcohol
|
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
|
GB201015371D0
(en)
*
|
2010-09-14 |
2010-10-27 |
Optinose As |
Nasal delivery
|
|
US8647661B1
(en)
*
|
2010-11-05 |
2014-02-11 |
Florida A&M University |
Surface modified multilayered nanostructures for dermal delivery
|
|
BR112013017296B1
(pt)
|
2011-01-11 |
2021-02-17 |
Signature Therapeutics, Inc. |
composto e composição compreendendo oxicodona, método para reduzir o abuso potencial da referida composição, unidade de dose e método para a sua preparação, e método para identificar um composto e um inibidor de tripsina
|
|
WO2012096886A1
(en)
|
2011-01-11 |
2012-07-19 |
Signature Therapeutics, Inc. |
Compositions comprising enzyme-cleavable oxycodone prodrug
|
|
US20120183580A1
(en)
*
|
2011-01-13 |
2012-07-19 |
Theralpha |
Analgesic Composition for Transbuccal Administration
|
|
US11523934B2
(en)
|
2011-02-04 |
2022-12-13 |
Seed Health, Inc. |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US12279989B2
(en)
|
2011-02-04 |
2025-04-22 |
Seed Health, Inc. |
Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
|
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
|
US10687975B2
(en)
*
|
2011-02-04 |
2020-06-23 |
Joseph E. Kovarik |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
|
US11998479B2
(en)
|
2011-02-04 |
2024-06-04 |
Seed Health, Inc. |
Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
|
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
|
US12257272B2
(en)
|
2015-12-24 |
2025-03-25 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing depression in an individual
|
|
JP6148182B2
(ja)
|
2011-03-09 |
2017-06-14 |
シグネーチャー セラピューティクス, インク.Signature Therapeutics, Inc. |
複素環式リンカーを有する活性薬剤プロドラッグ
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
US9949923B2
(en)
*
|
2011-03-15 |
2018-04-24 |
Optinose As |
Nasal delivery
|
|
LT2694049T
(lt)
|
2011-04-05 |
2018-12-27 |
GrĆ¼nenthal GmbH |
Tapentadolis, skirtas skausmo perėjimo į lėtinį prevencijai
|
|
JP6040219B2
(ja)
*
|
2011-04-05 |
2016-12-07 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
三叉神経因性痛に伴う疼痛の治療用タペンタドール
|
|
SI2701693T1
(sl)
|
2011-04-29 |
2017-11-30 |
Gruenenthal Gmbh |
Tapentadol za preprečevanje in zdravljenje depresije in anksioznosti
|
|
US8609088B2
(en)
|
2011-05-10 |
2013-12-17 |
Regents Of The University Of Minnesota |
Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
|
|
WO2012174481A1
(en)
|
2011-06-15 |
2012-12-20 |
Nerve Access, Inc. |
Pharmaceutical compositions for intranasal administration for the treatment of neurodegenerative disorders
|
|
WO2013067309A1
(en)
*
|
2011-11-04 |
2013-05-10 |
Xion Pharmaceutical Corporation |
Methods and compositions for oral administration of melanocortin receptor agonist compounds
|
|
US11213501B2
(en)
|
2011-12-27 |
2022-01-04 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US9962391B2
(en)
|
2011-12-27 |
2018-05-08 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US9468599B2
(en)
|
2011-12-27 |
2016-10-18 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US11213500B2
(en)
|
2011-12-27 |
2022-01-04 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US10813897B2
(en)
|
2011-12-27 |
2020-10-27 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
WO2013103936A1
(en)
*
|
2012-01-05 |
2013-07-11 |
Beech Tree Labs, Inc. |
Method of treating pain by administration of nerve growth factor
|
|
US9707414B2
(en)
|
2012-02-14 |
2017-07-18 |
Rainbow Medical Ltd. |
Reflectance-facilitated ultrasound treatment and monitoring
|
|
CA2864606C
(en)
|
2012-02-15 |
2021-06-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of treating and preventing diseases and disorders of the central nervous system
|
|
EP2877189B1
(en)
|
2012-07-20 |
2021-01-06 |
Taiga Biotechnologies, Inc. |
Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
|
|
ES2442242B1
(es)
*
|
2012-08-09 |
2014-11-25 |
Biotechnology Institute, I Mas D, S.L. |
Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.
|
|
US9770593B2
(en)
|
2012-11-05 |
2017-09-26 |
Pythagoras Medical Ltd. |
Patient selection using a transluminally-applied electric current
|
|
CN104902836B
(zh)
|
2012-11-05 |
2017-08-08 |
毕达哥拉斯医疗有限公司 |
受控组织消融
|
|
WO2014085571A1
(en)
*
|
2012-11-28 |
2014-06-05 |
Nektar Therapeutics |
Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase i inhibitor
|
|
US9050330B2
(en)
*
|
2012-12-06 |
2015-06-09 |
Jose C. Ramon-de-Jesus |
Method, composition and kit for treating frequent headaches
|
|
US10639439B2
(en)
|
2013-01-30 |
2020-05-05 |
Midwest Pharmaceuticals, Llc |
Smokeless THC and administration method thereof
|
|
WO2014130581A1
(en)
*
|
2013-02-20 |
2014-08-28 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of migraine headache
|
|
US9365825B2
(en)
|
2013-03-11 |
2016-06-14 |
Taiga Biotechnologies, Inc. |
Expansion of adult stem cells in vitro
|
|
US10272115B2
(en)
|
2013-03-11 |
2019-04-30 |
Taiga Biotechnologies, Inc. |
Production and use of red blood cells
|
|
CA2906737C
(en)
|
2013-03-15 |
2023-08-15 |
Amgen Inc. |
Human pac1 antibodies
|
|
RU2692251C2
(ru)
|
2013-05-15 |
2019-06-24 |
Риджентс Оф Зэ Юниверсити Оф Миннесота |
Опосредованный аденоассоциированным вирусом перенос генов в центральную нервную систему
|
|
US20150086616A1
(en)
*
|
2013-09-20 |
2015-03-26 |
Steven Lehrer |
Method for the prevention and treatment of alzheimer's disease
|
|
US12246043B2
(en)
|
2013-12-20 |
2025-03-11 |
Seed Health, Inc. |
Topical application to treat acne vulgaris
|
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
|
US12329783B2
(en)
|
2013-12-20 |
2025-06-17 |
Seed Health, Inc. |
Method and system to improve the health of a person's skin microbiome
|
|
US12005085B2
(en)
|
2013-12-20 |
2024-06-11 |
Seed Health, Inc. |
Probiotic method and composition for maintaining a healthy vaginal microbiome
|
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
|
US11998574B2
(en)
|
2013-12-20 |
2024-06-04 |
Seed Health, Inc. |
Method and system for modulating an individual's skin microbiome
|
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
|
AU2015230933B2
(en)
|
2014-03-21 |
2020-08-13 |
Teva Pharmaceuticals International Gmbh |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
|
US10556945B2
(en)
|
2014-03-21 |
2020-02-11 |
Teva Pharmaceuticals International Gmbh |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
|
EP3139853B1
(en)
|
2014-05-07 |
2018-12-19 |
Pythagoras Medical Ltd. |
Controlled tissue ablation apparatus
|
|
AU2015277272A1
(en)
*
|
2014-06-16 |
2017-01-12 |
Loewi LLC |
Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
|
|
WO2016044224A1
(en)
|
2014-09-15 |
2016-03-24 |
Amgen Inc. |
Bi-specific anti-cgrp receptor/pac1 receptor antigen binding proteins and uses thereof
|
|
ES2690140T3
(es)
*
|
2014-10-01 |
2018-11-19 |
Oxytone Bioscience B.V. |
Unidad de dosificación farmacéutica sólida de desintegración oral que contiene una sustancia de control del parto
|
|
WO2016053091A1
(en)
*
|
2014-10-01 |
2016-04-07 |
Oxytone Bioscience B.V. |
Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance
|
|
PT3848028T
(pt)
|
2014-10-20 |
2024-09-20 |
Oyster Point Pharma Inc |
Métodos de tratamento de estados oculares
|
|
EP3209803A4
(en)
|
2014-10-21 |
2018-06-13 |
Ubiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics
|
|
US10388407B2
(en)
|
2014-10-21 |
2019-08-20 |
uBiome, Inc. |
Method and system for characterizing a headache-related condition
|
|
JP6990583B2
(ja)
|
2014-11-19 |
2022-01-12 |
オプティノーズ アズ |
鼻腔内投与
|
|
JP2017536421A
(ja)
*
|
2014-12-01 |
2017-12-07 |
アケリオス セラピューティクス，インコーポレーテッド |
片頭痛及び疼痛に関連する状態を処置するための方法及び組成物
|
|
JP7030517B2
(ja)
|
2015-01-07 |
2022-03-07 |
トライジェミナ， インコーポレイテッド |
マグネシウム含有オキシトシン製剤および使用の方法
|
|
US9937223B2
(en)
|
2015-01-30 |
2018-04-10 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9744239B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9925233B2
(en)
|
2015-01-30 |
2018-03-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9744209B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9687526B2
(en)
|
2015-01-30 |
2017-06-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
US9750785B2
(en)
|
2015-01-30 |
2017-09-05 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
|
CN107613768B
(zh)
|
2015-02-12 |
2020-10-20 |
NeOnc技术股份有限公司 |
包含紫苏醇衍生物的药物组合物
|
|
WO2016140063A1
(ja)
*
|
2015-03-04 |
2016-09-09 |
栄研化学株式会社 |
オキシトシンの高感度測定法
|
|
AU2016249408A1
(en)
|
2015-04-16 |
2017-11-09 |
H. Lundbeck A/S. |
Anti-PACAP antibodies and uses thereof
|
|
US10383685B2
(en)
|
2015-05-07 |
2019-08-20 |
Pythagoras Medical Ltd. |
Techniques for use with nerve tissue
|
|
US11207461B2
(en)
|
2015-07-30 |
2021-12-28 |
Anoop U. R |
Drug delivery system and method for controlled and continuous delivery of drugs into the brain by bypassing the blood brain barrier
|
|
US11213480B1
(en)
|
2015-08-06 |
2022-01-04 |
Hikma Pharmaceuticals International Limited |
Phenylephrine hydrochloride ready-to-use solution
|
|
US10335406B2
(en)
|
2015-10-01 |
2019-07-02 |
Elysium Therapeutics, Inc. |
Opioid compositions resistant to overdose and abuse
|
|
GB2556817B
(en)
|
2015-10-01 |
2019-11-06 |
Elysium Therapeutics Inc |
Polysubunit opioid prodrugs resistant to overdose and abuse
|
|
WO2017106578A1
(en)
|
2015-12-15 |
2017-06-22 |
Amgen Inc. |
Pacap antibodies and uses thereof
|
|
CN115814055A
(zh)
*
|
2016-04-12 |
2023-03-21 |
三叉神经股份公司 |
含镁催产素制剂和应用方法
|
|
JP2019515671A
(ja)
|
2016-04-15 |
2019-06-13 |
アルダー バイオファーマシューティカルズ、インコーポレイテッド |
抗ｐａｃａｐ抗体及びそれらの使用
|
|
WO2017181113A1
(en)
|
2016-04-15 |
2017-10-19 |
The Trustees Of The University Of Pennsyvania |
Gene therapy for treating mucopolysaccharidosis type ii
|
|
WO2017199240A2
(en)
|
2016-05-18 |
2017-11-23 |
Pythagoras Medical Ltd. |
Helical catheter
|
|
KR20220031944A
(ko)
|
2016-09-23 |
2022-03-14 |
테바 파마슈티컬스 인터내셔널 게엠베하 |
불응성 편두통의 치료
|
|
WO2018094376A1
(en)
*
|
2016-11-21 |
2018-05-24 |
uBiome, Inc. |
Method and system for characterizing a headache-related condition
|
|
CN110267538B
(zh)
|
2016-11-30 |
2022-04-19 |
尼昂克技术公司 |
紫苏醇-3-溴丙酮酸缀合物和治疗癌症的方法
|
|
EP4242298A2
(en)
|
2016-12-02 |
2023-09-13 |
Taiga Biotechnologies, Inc. |
Nanoparticle formulations
|
|
US10456419B2
(en)
|
2017-02-27 |
2019-10-29 |
Payman Sadeghi |
Method for treating migraine headaches
|
|
US10932711B2
(en)
|
2017-02-27 |
2021-03-02 |
Payman Sadeghi |
Method and system for neurohydrodissection
|
|
EP3595663A4
(en)
|
2017-03-17 |
2021-01-13 |
Elysium Therapeutics, Inc. |
MULTI-UNIT OPIOID MEDICINES RESISTANT TO OVERDOSE AND ABUSE
|
|
US10149898B2
(en)
|
2017-08-03 |
2018-12-11 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|
|
TWI835747B
(zh)
|
2017-09-22 |
2024-03-21 |
賓州大學委員會 |
用於治療黏多醣病 ii 型之基因治療
|
|
JP7339262B2
(ja)
|
2018-01-12 |
2023-09-05 |
アムジェン インコーポレイテッド |
Ｐａｃ１抗体及びその使用
|
|
JP7325425B2
(ja)
|
2018-02-08 |
2023-08-14 |
ネオンク テクノロジーズ インク． |
血液脳関門を透過性にする方法
|
|
WO2020061584A1
(en)
*
|
2018-09-21 |
2020-03-26 |
Msb Holdings, Inc. |
Taste-masked dosage forms
|
|
US11135379B2
(en)
|
2019-02-15 |
2021-10-05 |
Bn Intellectual Properties, Inc. |
Method of delivering pharmaceutical products
|
|
BR112021018086A2
(pt)
|
2019-03-14 |
2021-11-23 |
Univ Arizona |
Método de tratamento e/ou prevenção de asma, exacerbações de asma, asma alérgica e/ou condições associadas com microbiota relacionadas a distúrbios respiratórios
|
|
AU2020272664A1
(en)
|
2019-04-08 |
2021-11-04 |
Taiga Biotechnologies, Inc. |
Compositions and methods for the cry opreservation of immune cells
|
|
AU2020274117A1
(en)
|
2019-05-14 |
2021-12-02 |
Taiga Biotechnologies, Inc. |
Compositions and methods for treating T cell exhaustion
|
|
WO2021016190A1
(en)
*
|
2019-07-19 |
2021-01-28 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Compositions and methods for modulating drug-use disorders
|
|
US11364225B2
(en)
*
|
2019-08-21 |
2022-06-21 |
Bn Intellectual Properties, Inc. |
Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same
|
|
US11241477B2
(en)
*
|
2019-08-29 |
2022-02-08 |
New York University |
Oxytocin compositions for treatment of tinnitus
|
|
WO2021072055A1
(en)
*
|
2019-10-11 |
2021-04-15 |
Board Of Regents, The University Of Texas System |
Compositions and methods for preventing, reducing and reversing opioid-induced respiratory depression
|
|
CA3165957A1
(en)
|
2020-01-24 |
2021-07-29 |
Thomas K. EQUELS |
Methods, compositions, and vaccines for treating a virus infection
|
|
WO2023048748A1
(en)
*
|
2020-08-10 |
2023-03-30 |
Ziropa, Inc. |
Compositions and methods for topical delivery
|
|
MX2024003466A
(es)
|
2021-09-29 |
2024-06-04 |
Ensysce Biosciences Inc |
Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.
|
|
JP2025504069A
(ja)
*
|
2022-01-27 |
2025-02-06 |
ベルナップ ファーマシューティカルズ， エルエルシー |
オキシトシンを使用した治療方法
|
|
AU2023375349A1
(en)
*
|
2022-11-07 |
2025-05-22 |
AEON Biopharma, Inc. |
Compositions for use in treating headache disorders
|
|
WO2025064708A1
(en)
*
|
2023-09-22 |
2025-03-27 |
The George Washington University |
Compositions comprising oxytocin and methods of treating opioid overdose
|
|
WO2025199179A2
(en)
|
2024-03-18 |
2025-09-25 |
Tonix Pharmaceuticals Holding Corp. |
Oxytocin peptide analogs
|